U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
--------------------------------------------------------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): October 9, 2002
AMEDISYS, INC.
--------------
(Exact Name of Registrant as Specified in Charter)
Delaware
--------
(State or Other Jurisdiction of
Incorporation or Organization)
0-24260 11-3131700
-------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
-------------------------------------------------
(Address of principal executive offices including zip code)
(225) 292-2031
--------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
On October 9, 2002, Amedisys, Inc., "the Company", issued a
press release attached hereto as Exhibit 99.1 to announce that the
Company's common stock has been approved for listing on the NASDAQ
National Market System.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibit
No. Page
------- ----
99.1 (i) Press release dated October 9, 2002 to announce
Amedisys approval to list its common stock on the
NASDAQ National Market System ............................ A-1
(i) Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By: /s/ GREGORY H. BROWNE
---------------------------
Gregory H. Browne
Chief Financial Officer
DATE: October 11, 2002
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 (i) Press release dated October 9, 2002 to announce
Amedisys approval to list its common stock on the
NASDAQ National Market System
(i) Filed herewith.